Statins row blamed for drop in drug use

A row over widening the use of statins to prevent heart disease may have deterred thousands of people from using the drugs, according to a survey of heart specialists.

As many as 79% of specialists believe that reporting of the row has confused patients about the role of statins, according to the British Cardiovascular Society.

The dispute was triggered when the National Institute for Health and Care Excellence proposed that doctors make wider use of statins.

But The British Medical Journal was also at the centre of controversy over the publication of articles claiming the drugs had hidden side-effects. It was later forced to withdraw some of the allegations.

The NICE guidance provoked concern from many senior doctors after suggesting that doctors cut the threshold for offering the drug to people at risk of developing heart disease.

Some 2,374 members of the British Cardiovascular Society took part in the survey and 59% said they believed some patients had stopped taking statins because of the controversy.

And nearly a third – 30% – said that more than five patients had stopped taking the drugs.

Dr Mike Knapton, of the British Heart Foundation, said many people might have misunderstood the debate about the drugs.

He said: "Evidence shows that statins are a safe, effective, cholesterol-lowering drug and proven to lower the risk of heart disease.

"Rightly, there was a debate over widening their availability to people but this may have been misinterpreted as a debate on their validity as a treatment.

"Anyone who has already been prescribed statins should continue to take them as advised by their doctor to help maintain a healthy heart.

"But just as important is the emphasis on trying lifestyle changes before considering treatments with drugs."

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index